Skip to main content
Erschienen in: Documenta Ophthalmologica 1/2008

01.01.2008 | Case Report

Cancer-associated retinopathy (CAR) with electronegative ERG: a case report

verfasst von: Griet Goetgebuer, Anna-Maria Kestelyn-Stevens, Jean-Jacques De Laey, Philippe Kestelyn, Bart P. Leroy

Erschienen in: Documenta Ophthalmologica | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Cancer-associated retinopathy (CAR) should be suspected in patients who present with visual symptoms such as rapid unexplained visual loss and seeing shimmering lights, with an abnormal ERG. Electronegative ERG responses are not exclusive to melanoma-associated retinopathy (MAR) but may be seen in CAR as well. We describe a patient with CAR who presented with an electronegative ERG. A 67-year old woman, who presented with complaints of seeing shimmering lights, underwent an extensive ophthalmological and electrophysiological examination. Best-corrected visual acuity was 7/10 in the right and 9/10 in the left eye. Goldmann visual fields showed relative central scotomata and concentric narrowing. Slit-lamp and fundus examination were normal as was fluorescein angiography. Rod-specific ERG responses were severely reduced, with electronegative maximal combined rod-cone responses and delayed cone-responses with normal amplitudes. Melanoma-associated retinopathy was suspected. Extensive dermatological and internal evaluation eventually revealed an oat-cell carcinoma in the right lung. The patient died of pneumonia 2 years after presentation.
Literatur
1.
Zurück zum Zitat Bataller L, Dalmau J (2004) Neuro-ophthalmology and paraneoplastic syndromes. Curr Opin Neurol 17:3–8PubMedCrossRef Bataller L, Dalmau J (2004) Neuro-ophthalmology and paraneoplastic syndromes. Curr Opin Neurol 17:3–8PubMedCrossRef
2.
Zurück zum Zitat Ling CP, Pavesio C (2003) Paraneoplastic syndromes associated with visual loss. Curr Opin Ophthalmol 14:426–32PubMedCrossRef Ling CP, Pavesio C (2003) Paraneoplastic syndromes associated with visual loss. Curr Opin Ophthalmol 14:426–32PubMedCrossRef
3.
Zurück zum Zitat Chan JW (2003) Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 48:12–38PubMedCrossRef Chan JW (2003) Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 48:12–38PubMedCrossRef
4.
Zurück zum Zitat Robertson DM (2002) Non-cancerous ophthalmic clues to non-ocular cancer. Surv Ophthalmol 47:397–430PubMedCrossRef Robertson DM (2002) Non-cancerous ophthalmic clues to non-ocular cancer. Surv Ophthalmol 47:397–430PubMedCrossRef
5.
Zurück zum Zitat Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606–613PubMed Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606–613PubMed
6.
Zurück zum Zitat Berson EL, Lessell S (1988) Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 106:307–311PubMedCrossRef Berson EL, Lessell S (1988) Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 106:307–311PubMedCrossRef
7.
Zurück zum Zitat Hooks JJ, Tso MO, Detrick B (2001) Retinopathies associated with antiretinal antibodies. Clin Diagn Lab Immunol 8:853–858PubMedCrossRef Hooks JJ, Tso MO, Detrick B (2001) Retinopathies associated with antiretinal antibodies. Clin Diagn Lab Immunol 8:853–858PubMedCrossRef
8.
Zurück zum Zitat Cohen RG, Rizzo J III, Lou P (1997) New developments in cancer-associated retinopathy. Int Ophthalmol Clin 37:233–250PubMedCrossRef Cohen RG, Rizzo J III, Lou P (1997) New developments in cancer-associated retinopathy. Int Ophthalmol Clin 37:233–250PubMedCrossRef
9.
10.
Zurück zum Zitat Keltner JL, Thirkill CE, Yip PT (2001) Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21:173–187PubMed Keltner JL, Thirkill CE, Yip PT (2001) Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21:173–187PubMed
11.
Zurück zum Zitat Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MO (1992) ‘On’ response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 33:477–483PubMed Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MO (1992) ‘On’ response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 33:477–483PubMed
12.
Zurück zum Zitat Boeck K, Hofmann S, Klopfer M, Ian U, Schmidt T, Engst R, Thirkill CE, Ring J (1997) Melanoma-associated paraneoplastic retinopathy: case report and review of the literature. Br J Dermatol 137:457–460PubMedCrossRef Boeck K, Hofmann S, Klopfer M, Ian U, Schmidt T, Engst R, Thirkill CE, Ring J (1997) Melanoma-associated paraneoplastic retinopathy: case report and review of the literature. Br J Dermatol 137:457–460PubMedCrossRef
13.
Zurück zum Zitat Chan C, O’Day J (2001) Melanoma-associated retinopathy: does autoimmunity prolong survival? Clin Exp Ophthalmol 29:235–238CrossRef Chan C, O’Day J (2001) Melanoma-associated retinopathy: does autoimmunity prolong survival? Clin Exp Ophthalmol 29:235–238CrossRef
14.
Zurück zum Zitat Milam AH, Saari JC, Jacobson SG, Lubinski WP, Feun LG, Alexander KR (1993) Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 34:91–100PubMed Milam AH, Saari JC, Jacobson SG, Lubinski WP, Feun LG, Alexander KR (1993) Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 34:91–100PubMed
15.
Zurück zum Zitat Potter MJ, Adamus G, Szabo SM, Lee R, Mohaseb K, Behn D (2002) Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol 134:128–130PubMedCrossRef Potter MJ, Adamus G, Szabo SM, Lee R, Mohaseb K, Behn D (2002) Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol 134:128–130PubMedCrossRef
16.
Zurück zum Zitat Solomon SD, Smith JH, O’Brien J (1999) Ocular manifestations of systemic malignancies. Curr Opin Ophthalmol 10:447–451PubMedCrossRef Solomon SD, Smith JH, O’Brien J (1999) Ocular manifestations of systemic malignancies. Curr Opin Ophthalmol 10:447–451PubMedCrossRef
17.
Zurück zum Zitat Scholl HP, Zrenner E (2000) Electrophysiology in the investigation of acquired retinal disorders. Surv Ophthalmol 45:29–47PubMedCrossRef Scholl HP, Zrenner E (2000) Electrophysiology in the investigation of acquired retinal disorders. Surv Ophthalmol 45:29–47PubMedCrossRef
18.
Zurück zum Zitat Koh AH, Hogg CR, Holder GE (2001) The incidence of negative ERG in clinical practice. Doc Ophthalmol 102:19–30PubMedCrossRef Koh AH, Hogg CR, Holder GE (2001) The incidence of negative ERG in clinical practice. Doc Ophthalmol 102:19–30PubMedCrossRef
19.
Zurück zum Zitat Alexander KR, Barnes CS, Fishman GA, Milam AH (2002) Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 43:1189–1197PubMed Alexander KR, Barnes CS, Fishman GA, Milam AH (2002) Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 43:1189–1197PubMed
20.
Zurück zum Zitat Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41:262–266PubMed Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41:262–266PubMed
21.
Zurück zum Zitat Ladewig G, Reinhold U, Thirkill CE, Kerber A, Tilgen W, Pfohler C (2005) Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. Br J Dermatol 152:931–938PubMedCrossRef Ladewig G, Reinhold U, Thirkill CE, Kerber A, Tilgen W, Pfohler C (2005) Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. Br J Dermatol 152:931–938PubMedCrossRef
22.
Zurück zum Zitat Jacobson DM, Adamus G (2001) Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma. Am J Ophthalmol 131:806–808PubMedCrossRef Jacobson DM, Adamus G (2001) Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma. Am J Ophthalmol 131:806–808PubMedCrossRef
23.
Zurück zum Zitat Masaoka N, Emoto Y, Sasaoka A, Fukushima A, Ueno H, Ohguro H (1999) Fluorescein angiographic findings in a case of cancer-associated retinopathy. Retina 19:462–464PubMedCrossRef Masaoka N, Emoto Y, Sasaoka A, Fukushima A, Ueno H, Ohguro H (1999) Fluorescein angiographic findings in a case of cancer-associated retinopathy. Retina 19:462–464PubMedCrossRef
24.
Zurück zum Zitat Ohguro H, Yokoi Y, Ohguro I, Mamiya K, Ishikawa F, Yamazaki H, Metoki T, Takano Y, Ito T, Nakazawa M (2004) Clinical and immunologic aspects of cancer-associated retinopathy. Am J Ophthalmol 137:1117–1119PubMedCrossRef Ohguro H, Yokoi Y, Ohguro I, Mamiya K, Ishikawa F, Yamazaki H, Metoki T, Takano Y, Ito T, Nakazawa M (2004) Clinical and immunologic aspects of cancer-associated retinopathy. Am J Ophthalmol 137:1117–1119PubMedCrossRef
25.
Zurück zum Zitat Dot C, Guigay J, Adamus G (2005) Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. Am J Ophthalmol 139:746–747PubMedCrossRef Dot C, Guigay J, Adamus G (2005) Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. Am J Ophthalmol 139:746–747PubMedCrossRef
26.
Zurück zum Zitat Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, Adamus G (2005) Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 139:780–794PubMedCrossRef Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, Adamus G (2005) Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 139:780–794PubMedCrossRef
Metadaten
Titel
Cancer-associated retinopathy (CAR) with electronegative ERG: a case report
verfasst von
Griet Goetgebuer
Anna-Maria Kestelyn-Stevens
Jean-Jacques De Laey
Philippe Kestelyn
Bart P. Leroy
Publikationsdatum
01.01.2008
Verlag
Springer-Verlag
Erschienen in
Documenta Ophthalmologica / Ausgabe 1/2008
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-007-9074-9

Weitere Artikel der Ausgabe 1/2008

Documenta Ophthalmologica 1/2008 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.